Skip to content

ADMA Biologics ADMA Federal taxes

Federal taxes at other companies

Zymeworks logo
ZymeworksZYME
$53.25K
Charles River Laboratories logo
Charles River LaboratoriesCRL
$10.57M

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.02B-54.5%

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxPaidFederalAfterRefundReceived.

The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's federal taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's federal taxes?
ADMA Biologics (ADMA) reported federal taxes of $4.4M in Q4 2025.
What does federal taxes mean?
The actual cash outflow for federal income taxes paid to the national government during the period, net of any refunds received. This metric provides insight into the company's cash tax burden versus its accounting tax provision. It is a critical component for assessing cash flow generation and tax efficiency.